PTC Therapeutics Inc (NAS:PTCT)
$ 44.225 -0.395 (-0.89%) Market Cap: 3.40 Bil Enterprise Value: 2.83 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 65/100

Q4 2022 PTC Therapeutics Inc Earnings Call Transcript

Feb 21, 2023 / 09:30PM GMT
Release Date Price: $44.72 (-4.20%)
Operator

Good day, and welcome to the PTC Therapeutics Fourth Quarter 2022 Corporate Update and Financial Results Call. (Operator Instructions) As a reminder, this call is being recorded.

I would now like to turn the call over to Kylie O'Keefe, Chief Commercial Officer. You may begin.

Kylie O;Keefe
PTC Therapeutics, Inc. - Chief Commercial Officer

' -

Good afternoon, and thank you for joining us today to discuss PTC Therapeutics' Fourth Quarter 2022 Corporate Update and Financial Results. I'm joined today by our Chief Executive Officer, Stuart Peltz; our Chief Operating Officer, Matthew Klein; our Chief Business Officer, Eric Pauwels; and our Chief Financial Officer, Emily Hill.

Today's call will include forward-looking statements based on our current expectations. Please take a moment to review the slide posted on our Investor Relations website in conjunction with the call, which contains our forward-looking statements. Our actual results could materially differ from these forward-looking statements. As such, statements are subject to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot